Yesterday at 12:17 PM
Moderna Inc, an American pharmaceutical company located in Cambridge, Massachusetts, hasn’t approved the transfer of its intellectual property rights for the developed mRNA vaccine against COVID-19 to China. The refusal led to the failure of negotiations with China on selling the vaccine in the country.
The company explained its refusal to reveal the vaccine technology by commercial and safety reasons.